Q4 2024 13F Holders as of 12/31/2024
-
Type / Class
-
Equity / Common Stock
-
Shares outstanding
-
57.1M
-
Number of holders
-
244
-
Total 13F shares, excl. options
-
52.7M
-
Shares change
-
+2.76M
-
Total reported value, excl. options
-
$1.81B
-
Value change
-
+$76.2M
-
Put/Call ratio
-
0.42
-
Number of buys
-
155
-
Number of sells
-
-73
-
Price
-
$34.41
Significant Holders of Harmony Biosciences Holdings, Inc. - Common Stock (HRMY) as of Q4 2024
274 filings reported holding HRMY - Harmony Biosciences Holdings, Inc. - Common Stock as of Q4 2024.
Harmony Biosciences Holdings, Inc. - Common Stock (HRMY) has 244 institutional shareholders that have filed 13F forms with the Securities Exchange Commission (SEC).
These institutions hold a total of 52.7M shares
of 57.1M outstanding shares and own 92.28% of the company stock.
Largest 10 shareholders include BlackRock, Inc. (6.97M shares), Valor Management LLC (6.62M shares), FMR LLC (5.33M shares), VANGUARD GROUP INC (4.73M shares), Pacer Advisors, Inc. (2.28M shares), STATE STREET CORP (1.58M shares), Deep Track Capital, LP (1.45M shares), CITADEL ADVISORS LLC (1.37M shares), DIMENSIONAL FUND ADVISORS LP (1.21M shares), and AMERICAN CENTURY COMPANIES INC (1.1M shares).
This table shows the top 244 institutional shareholders of the company equity. This data is sourced directly from the SEC via 13F filings.
| Investor |
Option |
Weight % |
Change % |
Value $ |
* Price $ |
Shares |
Share Change |
Activity |
Report Period |
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.